Bio-IT World May 19, 2021
Deborah Borfitz

Genomic technologies are expected to be a mainstay of medicine within the next decade, but it is not entirely clear how to bring the resulting information into clinical care. The Institute for Genomic Health was established at Mount Sinai Health System two years ago to bridge that gap, says Founding Director Eimear Kenny, Ph.D., professor of medicine, and genetics and genomic sciences in the Icahn School of Medicine at Mount Sinai.

The idea is to launch pilot programs in the clinic based on discoveries from genomic research to evaluate their real-world utility, says Kenny. Where genomics data proves useful, the necessary infrastructure then gets built in terms of educating medical professionals and creating navigational paths for patients to bring that...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Health System / Hospital, Pharma / Biotech, Precision Medicine, Provider
Pharma Pulse 11/25/24: Deepening Patient Relationships, Menopause May Increase Risk of Asthma & more
Axolotl Biosciences Brings Biotech to the Forefront at Formnext 2024
Innovative approach maps gene activity in the living human brain
Trump tariffs could drive up generic drug costs: 5 takeaways
Answer ALS, Cedars-Sinai Collaboration, Single-Cell Protein Profiling, ChapsVision Acquires Sinequa, More

Share This Article